Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 4, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jayson Bedford Maintained (TNDM) at Buy with Decreased Target to $90 on, Aug 4th, 2022
Jayson Bedford of Raymond James, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Decreased Target from $125 to $90 on, Aug 4th, 2022.
Jayson has made no other calls on TNDM in the last 4 months.
There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, 1 agrees with Jayson's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $110 on, Thursday, May 5th, 2022
This is the rating of the analyst that currently disagrees with Jayson
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $130 on, Tuesday, May 17th, 2022
